Evidence map›Paper›PMID 33462367›Full record

ReviewModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2021

Papillary neoplasms of the breast-reviewing the spectrum.

Timothy Kwang Yong Tay, Puay Hoon Tan

Abstract readReview
PubMed Publisher
In one paragraph

Review in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Metastasis ofFrontiers in oncology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Invasive papillary carcinoma of the breast.Frontiers in oncology · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. Pitfalls in breast pathology.Histopathology · 2023
    Review
  17. Article
  18. Papillary lesions of the breast.Virchows Archiv : an international journal of pathology · 2022
    Review
  19. Article
  20. Breast carcinomas of low malignant potential.Virchows Archiv : an international journal of pathology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Timothy Kwang Yong TayDepartment of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.
Puay Hoon TanDivision of Pathology, Singapore General Hospital, Singapore, Singapore. tan.puay.hoon@singhealth.com.sg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Papillary neoplasms of the breast encompass a wide range of tumor types ranging from the benign intraductal papilloma to in situ and invasive papillary carcinomas. In this review, we considered each tumor entity listed under the Papillary Neoplasms category in the latest WHO Classification of Breast Tumors (5th edition), namely intraductal papilloma, papillary ductal carcinoma in situ, encapsulated papillary carcinoma, solid-papillary carcinoma, and invasive papillary carcinoma. We examined their pathological features, current issues pertaining to diagnosis and prognostication, as well as the latest molecular findings. We also briefly addressed adenomyoepithelioma and the newly included tall cell carcinoma with reversed polarity, highlighting areas where they overlap with papillary neoplasms.

Indexed as

Breast NeoplasmsCarcinoma, Intraductal, NoninfiltratingCarcinoma, PapillaryFemaleHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.